Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Pfeifer

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Angewandte Chemie (International Ed. in English)|September 17, 2013
Dynamic nuclear polarization NMR spectroscopy: revealing multiple conformations in lipid-anchored peptide vaccinesEline J Koers, Maria Pilar López-Deber, Markus Weingarth, et al.
Bioorganic & Medicinal Chemistry|November 28, 2021
Structure-activity relationship around PI-2620 highlights the importance of the nitrogen atom position in the tricyclic coreHeiko Kroth, Felix Oden, Andreia Monica Serra, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2025
A single dose of a vectorized mAb targeting TDP-43 potently inhibits the neuropathology in a model of ALS/FTDGreg Del Val, Florence Gauye, Mickaël Audrain, et al.
Journal of Medicinal Chemistry|August 30, 2021
<b>PI-2620</b> Lead Optimization Highlights the Importance of Off-Target Assays to Develop a PET Tracer for the Detection of Pathological Aggregated Tau in Alzheimer's Disease and Other TauopathiesHeiko Kroth, Felix Oden, Jerome Molette, et al.
Journal of Alzheimer'S Disease : JAD|September 28, 2013
Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosisPaolo Paganetti, Katia Antoniello, Kavi Devraj, et al.
European Journal of Medicinal Chemistry|August 11, 2020
Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathiesEmanuele Gabellieri, Francesca Capotosti, Jerome Molette, et al.
Mabs|July 6, 2023
Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human frameworkRomain Ollier, Aline Fuchs, Florence Gauye, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2019
Tau PET imaging with <sup>18</sup>F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans StudyAndre Mueller, Santiago Bullich, Olivier Barret, et al.
Plos One|August 27, 2013
Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathyClara Theunis, Natalia Crespo-Biel, Valérie Gafner, et al.
Scientific Reports|December 21, 2016
Structure of Crenezumab Complex with Aβ Shows Loss of β-HairpinMark Ultsch, Bing Li, Till Maurer, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Angewandte Chemie (International Ed. in English)|September 17, 2013
Dynamic nuclear polarization NMR spectroscopy: revealing multiple conformations in lipid-anchored peptide vaccinesEline J Koers, Maria Pilar López-Deber, Markus Weingarth, et al.
Bioorganic & Medicinal Chemistry|November 28, 2021
Structure-activity relationship around PI-2620 highlights the importance of the nitrogen atom position in the tricyclic coreHeiko Kroth, Felix Oden, Andreia Monica Serra, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2025
A single dose of a vectorized mAb targeting TDP-43 potently inhibits the neuropathology in a model of ALS/FTDGreg Del Val, Florence Gauye, Mickaël Audrain, et al.
Journal of Medicinal Chemistry|August 30, 2021
<b>PI-2620</b> Lead Optimization Highlights the Importance of Off-Target Assays to Develop a PET Tracer for the Detection of Pathological Aggregated Tau in Alzheimer's Disease and Other TauopathiesHeiko Kroth, Felix Oden, Jerome Molette, et al.
Journal of Alzheimer'S Disease : JAD|September 28, 2013
Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosisPaolo Paganetti, Katia Antoniello, Kavi Devraj, et al.
European Journal of Medicinal Chemistry|August 11, 2020
Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathiesEmanuele Gabellieri, Francesca Capotosti, Jerome Molette, et al.
Mabs|July 6, 2023
Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human frameworkRomain Ollier, Aline Fuchs, Florence Gauye, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2019
Tau PET imaging with <sup>18</sup>F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans StudyAndre Mueller, Santiago Bullich, Olivier Barret, et al.
Plos One|August 27, 2013
Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathyClara Theunis, Natalia Crespo-Biel, Valérie Gafner, et al.
Scientific Reports|December 21, 2016
Structure of Crenezumab Complex with Aβ Shows Loss of β-HairpinMark Ultsch, Bing Li, Till Maurer, et al.
Pageof 6